In principle, we would expect the best vaccine might be a mixture of gp120 variants that replicated all of the potential glycan structures likely to be incorporated by the envelope proteins responsible for virus-mediated and cell-to-cell infection. This evidence concerns the gene ERVW-1 and infection.